开能健康: 关于可转换公司债券转股价格调整的公告

Group 1 - The company, Kaineng Health Technology Group Co., Ltd., has received approval from the China Securities Regulatory Commission to issue 2.5 million convertible bonds, raising a total of 250 million yuan, with a maturity period of six years from July 20, 2023, to July 19, 2029 [1] - The convertible bond, referred to as "Kaineng Convertible Bond," was listed on August 8, 2023 [1] - The adjustment of the conversion price for the convertible bonds will occur under specific circumstances such as stock dividends, capital increases, or cash dividends, following a defined formula [1][2] Group 2 - The conversion price adjustments will be announced on the Shenzhen Stock Exchange and other media, detailing the adjustment date and method [2] - Historical adjustments to the conversion price have occurred due to cash dividend distributions, with the price changing from 5.67 yuan to 5.62 yuan, and subsequently to 5.52 yuan, 5.47 yuan, and finally to 5.4 yuan [2][3][4] - The latest adjustment, effective from May 30, 2025, will reduce the conversion price from 5.4 yuan to 5.36 yuan due to a cash dividend distribution of 0.4 yuan per 10 shares [4]